Display Settings:


Send to:

Choose Destination
Ann Nucl Med. 2013 Apr;27(3):253-60. doi: 10.1007/s12149-013-0683-y. Epub 2013 Feb 5.

Monte Carlo simulations and radiation dosimetry measurements of 142Pr capillary tube-based radioactive implant (CTRI): a new structure for brachytherapy sources.

Author information

  • 1Department of Medical Radiation Engineering, Science and Research Branch, Islamic Azad University, 1454696111 Tehran, Iran. mk.bakht@gmail.com



Previously, a promising β(-)-emitting praseodymium-142 glass seed was proposed for brachytherapy of prostate cancer. In accordance with the previous study, a (142)Pr capillary tube-based radioactive implant (CTRI) was suggested as a source with a new structure to enhance application of β(-)-emitting radioisotopes such as (142)Pr in brachytherapy.


Praseodymium oxide powder was encapsulated in a glass capillary tube. Then, a thin and flexible fluorinated ethylene propylene Teflon(®) layer sealed the capillary tube. The source was activated in the Tehran Research Reactor by the (141)Pr(n,γ) (142)Pr reaction. Measurements of the dosimetric parameters were performed using GafChromic(®) radiochromic film. In addition, the dose rate distribution of (142)Pr CTRI was calculated by modeling (142)Pr source in a water phantom using Monte Carlo N-Particle Transport (MCNP5) Code.


The active source was unreactive and did not leak in water. In comparison with the earlier proposed (142)Pr seed, the suggested source showed similar desirable dosimetric characteristics. Moreover, the (142)Pr CTRI production procedure may be technically and economically more feasible. The mass of praseodymium in CTRI structure could be greater than that of the (142)Pr glass seed; therefore, the required irradiation time and the neutron flux could be reduced.


A (142)Pr CTRI was proposed for brachytherapy of prostate cancer. The dosimetric calculations by the experimental measurements and Monte Carlo simulation were performed to fulfill the requirements according to the American Association of Physicists in Medicine recommendations before the clinical use of new brachytherapy sources. The characteristics of the suggested source were compared with those of the previously proposed (142)Pr glass seed.

[PubMed - indexed for MEDLINE]
PubMed Commons home

PubMed Commons

How to join PubMed Commons

    Supplemental Content

    Icon for Springer
    Loading ...
    Write to the Help Desk